Saudi Arabia Health Insurance Market

The Saudi Arabia Health Insurance Market was valued at USD 12.45 billion in 2025, measured as gross written premiums covering Saudi health-insurance risks. The estimate is triangulated from insurer-level premium pools, an operational model based on 12.8 million insured lives and an independent demand-side calculation. Official 2024 data recorded SAR 42.25 billion in health premiums, which was advanced to 2025 using audited sector growth, company disclosures and mandatory-coverage developments. The estimated base-year confidence interval is USD 11.33 billion to USD 13.70 billion.

The market is forecast to reach USD 23.00 billion by 2031, expanding at a CAGR of 10.77% from 2025. Insured lives are expected to rise to 18.2 million, while average premium per life increases to approximately USD 1,264. Mandatory policy extensions, private employment, visitor coverage and chronic-care expenditure will support demand. Forecast growth remains lower than the 15.38% historical CAGR because the exceptional repricing and enrollment increases recorded during 2022 and 2023 are unlikely to recur at the same magnitude.

The largest absolute profit pool will remain employer group health insurance, but incremental value will shift toward SME, family, domestic-worker, visitor and digitally issued products. These segments benefit from standardized policy structures, embedded distribution and lower servicing costs. Managed-care and value-based contracts will also gain strategic importance because they can improve claims outcomes rather than relying solely on premium increases. Digital direct platforms are expected to be the fastest-growing distribution channel, while brokers remain important for complex corporate placements and benefit negotiations.

The principal risk is medical-cost growth exceeding premium adequacy. Saudi insurance-sector revenue increased in 2025, but the insurance service margin fell to 2.9% and net income declined by 40.8%. Health portfolios are particularly exposed to chronic disease, specialist treatment, pharmaceutical costs and provider-price escalation. Corporate contracts can also lock insurers into annual pricing while utilization changes during the policy period. Stronger authorization rules, provider contracting, fraud analytics and disease-management programs are therefore required to preserve underwriting margins.

Saudi Arabia ranks first among the selected GCC peers under a harmonized health-premium lens. Its estimated USD 12.45 billion market exceeds the UAE benchmark of approximately USD 9.27 billion and is substantially larger than Kuwait, Qatar and Oman. Saudi Arabia also has the strongest modeled forecast CAGR at 10.77%, compared with 8.26% for the UAE and 7.25% for Kuwait. Its larger private workforce, employer mandate, beneficiary base and centralized NPHIES exchange support scale advantages in provider negotiation and claims analytics.

The most important long-term factor is the expansion of eligible and insured populations through mandatory coverage and private-sector employment. The cooperative scheme covered approximately 12 million beneficiaries in 2023, with the modeled figure increasing to 12.8 million in 2025. A value-based-care study projected coverage could reach 22 million beneficiaries by 2030 under a broader financing transition. Chronic disease adds premium intensity, but membership expansion provides the larger structural volume opportunity across employers, dependents, domestic workers, visitors and pilgrims.